03 May 2023
03 May 2023
Maria (fictional name) has a scheduled surgical intervention to remove a malignant tumour from one of her breasts. She is the pre-op room, waiting to go into the OR, where the surgery will be performed under general anaesthetics. No wonder she feels anxious, her heart beats very fast, and she is unable to think about anything else right now. Her blood pressure is also going up.
27 April 2023
29th April is the birthday of Jean-Georges Noverre, creator of modern ballet, and to commemorate this, since 1982 it has also been International Dance Day. This day is dedicated to celebrating dance, revelling in the universality of this art form (across all political, cultural and ethnic barriers), and bringing people together within a common ‘language’.
20 April 2023
The second edition of the European Researchers’ Night (ERN), organised by the RAISE - Researchers in Action for Inclusion in Science and Education consortium will be held on the 29th of September 2023 and will, once again, take place at the Champalimaud Foundation (Lisbon).
The main goal of this public event, organised by consortium partners, Native Scientists, Champalimaud Foundation and Instituto de Medicina Molecular, is to promote, actively and effectively, diversity and inclusion in science and education.
A equipa de enfermagem do Centro Clínico Champalimaud organiza anualmente um congresso que pretende ser um momento de partilha de experiências entre profissionais de saúde e de promoção da reflexão sobre a prática clínica ao serviço dos doentes oncológicos e suas famílias.
12 April 2023
Carla Malveiro is responsible, at the Champalimaud Foundation (FC), for implementing oncological patients’ physical exercise programmes, particularly for women undergoing treatment at the Foundation’s Breast Unit. As a doctoral student from the Human Motricity Faculty (FMH) of the University of Lisbon, the 41-year-old exercise physiologist, specialising in oncology, has worked at the Foundation since October.
Cancer patients comprise about 15-20% of all patients admitted into Intensive Care Units (Bos et al. 2015; Shimalbukuro-Vornhagen et al. 2016); Approximately 50% of these admissions are due to surgical procedures, while the other 50% is related to medical causes, with only 3.3% corresponding to specific causes of oncological disease (Puxty et al. 2015).
03 April 2023
March was Multiple Myeloma Awareness Month. In this short video, Cristina João, Haemato-oncologist of the Haemato-oncology Unit at the Champalimaud Foundation, explains what this pathology is and talks about the activities that the Unit has developed for improving the care of people with Multiple Myeloma. She also points out that, in addition to clinical activity, the Haemato-Oncology Unit does translational research through the Foundation's Lymphoma and Myeloma Research Group, which she leads.
31 March 2023
Neste último vídeo da série, Laura Fernández, Cirurgiã Colorretal, fala da investigação da equipa sobre o Protocolo Watch&Wait (W&W).
Em estudos recentes, mostraram que a probabilidade de os doentes com cancro retal, que permanecem livres de tumores durante cinco anos, voltarem a desenvolver a doença é quase nula. Atualmente, a equipa está a tentar determinar quais os doentes, integrados no programa W&W, que serão mais susceptíveis de apresentar metástases.
On behalf of the International Cancer Imaging Society (ICIS) and the Champalimaud Foundation, we would like to invite you to register for our jointly hosted meeting 'AI and Machine Learning in Cancer Imaging 3.0', which will be held on 30 June and 1 July 2023. The meeting will take place at the Champalimaud Centre for the Unknown, in Lisbon.
30 March 2023
In Portugal, the winning scientists are Isabel Gordo (Gulbenkian Institute of Science, IGC), Maria Manuel Mota (João Lobo Antunes Institute of Molecular Medicine, iMM), Mariana Pinho (ITQB-NOVA) and Henrique Veiga-Fernandes (Champalimaud Foundation). Each will receive between €2.5M and €3.5M for the development of research projects over the next five years.